Regarding the effects of HER3 and MET on cancer cell proliferation, the combined stimulation of both ligands enhanced cell proliferation more than either ligand alone (Figure 2C), suggesting that HER3 and MET contribute to cell proliferation in a concerted manner. The gene discussed is ERBB3; the disease is cancer.